What is the most abundant type of collagen in hyaline cartilage?
Which one of the following occurs in ischemic cardiac tissue?
Botryoid odontogenic cyst is a variant of which of the following?
Which of the following is considered a chromosomal instability syndrome?
Which of the following stem cell populations are found in bone marrow except?
Which statement is not true regarding superantigens?
Metastatic calcification is most often seen in which of the following organs?
A 45-year-old man presents with a painless mass in the neck. A 4-cm firm, movable tumor is identified at the angle of the left jaw. A biopsy of the tumor reveals myoepithelial cells intermingled with myxoid, mucoid, and callaginous areas. The tumor is removed surgically. What is the most likely prognosis?
Rosenthal fibers in astrocytoma are composed of which of the following?
The BRAF gene is located on which chromosome?
Explanation: **Explanation:** The correct answer is **Type II Collagen**. **Why Type II is correct:** Collagen is the most abundant protein in the human body, and its distribution is tissue-specific. **Type II collagen** is the hallmark of **hyaline and elastic cartilage** [1]. It forms a dense network of thin fibrils that provide structural support and resist multi-directional pressure. In hyaline cartilage (found in articular surfaces, the trachea, and fetal skeletons), these fibrils are embedded in a ground substance rich in proteoglycans (like aggrecan), which helps maintain hydration and shock absorption. **Why other options are incorrect:** * **Type I:** This is the most abundant collagen overall in the body. It is found in high-tensile strength structures like **bone, skin, tendons, and ligaments** [2], as well as in **fibrocartilage** (e.g., intervertebral discs). * **Type III:** Also known as **reticulin**, it forms a structural framework (stroma) for highly cellular organs like the liver, spleen, and lymph nodes. It is also prominent in early wound healing (granulation tissue) before being replaced by Type I. * **Type IV:** This type does not form fibrils; instead, it forms a meshwork that constitutes the **basal lamina** (basement membrane). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Collagen Types:** * Type **I**: **B**one (and Skin/Tendon) * Type **II**: **C**artilage (Hyaline/Elastic) * Type **III**: **R**eticular fibers (Blood vessels/Early wound) * Type **IV**: **F**loor (Basement membrane) * **Stickler Syndrome:** A genetic mutation in Type II collagen leading to joint problems and retinal detachment. * **Alport Syndrome:** Mutation in Type IV collagen (affects kidneys, ears, and eyes). * **Ehlers-Danlos (Vascular type):** Associated with a deficiency in Type III collagen [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, p. 1188. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 154-155.
Explanation: In ischemia, the reduction in blood flow leads to a critical shortage of oxygen (hypoxia). This triggers a cascade of metabolic changes in the cardiac tissue: **Why Option B is Correct:** When oxygen levels drop, **oxidative phosphorylation** in the mitochondria fails, leading to a rapid decrease in ATP [1]. To compensate, the cell switches to **anaerobic glycolysis** to generate energy. This process utilizes glycogen stores to produce ATP in the absence of oxygen, resulting in the accumulation of **lactic acid** and inorganic phosphates [1], [2]. **Why the other options are Incorrect:** * **A. Increased ATP:** Ischemia causes a rapid **depletion of ATP**. Within seconds of hypoxia, mitochondrial respiration stops, and ATP levels begin to fall, leading to the failure of energy-dependent ion pumps [1], [2]. * **C. Increased pH:** Due to the accumulation of lactic acid (from anaerobic glycolysis) and protons, the intracellular **pH decreases** (acidosis), not increases [1], [2]. This acidic environment can lead to chromatin clumping and protein denaturation. * **D. Increased release of Calcium:** This is a distractor regarding the *timing*. While intracellular calcium eventually rises due to the failure of the Ca²⁺-ATPase pump (leading to influx from the ECF and release from the SR), this is a **consequence of ATP depletion** and occurs later in the injury phase [2]. The most immediate metabolic shift is the switch to anaerobic glycolysis. **NEET-PG High-Yield Pearls:** * **Earliest change in cell injury:** Decreased oxidative phosphorylation and ATP depletion [1]. * **First morphological sign of reversible injury:** Cellular swelling (due to failure of the Na⁺-K⁺ ATPase pump) [1]. * **Point of Irreversibility:** Marked by severe mitochondrial damage and extensive plasma membrane damage. * **Nuclear changes in necrosis:** Pyknosis (shrinkage) → Karyorrhexis (fragmentation) → Karyolysis (dissolution). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 55-57. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 548-550.
Explanation: **Explanation:** **Botryoid Odontogenic Cyst (BOC)** is a rare, multilocular variant of the **Lateral Periodontal Cyst (LPC)**. The term "botryoid" is derived from the Greek word for "cluster of grapes," which describes its characteristic gross and radiographic appearance. 1. **Why Option A is correct:** Both LPC and BOC arise from the remnants of the dental lamina (rests of Serres) [1]. While a standard LPC is typically unilocular and found between the roots of erupted teeth (most commonly in the mandibular canine-premolar area), the Botryoid variant represents a **multilocular** expansion. Histologically, both exhibit thin non-keratinized epithelium with focal thickenings (clear cell rests), but the BOC has a higher recurrence rate due to its multicystic nature. 2. **Why other options are incorrect:** * **Apical periodontal cyst (Radicular cyst):** This is an inflammatory cyst associated with a non-vital tooth at the apex, not a developmental cyst like BOC [1]. * **Gingival cysts of newborns (Bohn’s nodules):** These are small, keratin-filled cysts found on the alveolar ridges of infants that usually rupture and disappear spontaneously. * **Gingival cysts of adults:** While histologically similar to LPC (representing the soft-tissue counterpart), they occur in the gingival soft tissues and do not show the multilocular intraosseous "grape-like" pattern of BOC. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Mandibular premolar-canine region (80% of cases). * **Radiographic feature:** "Grape-like" multilocular radiolucency. * **Histology:** Look for **clear cells** rich in glycogen within the epithelial lining. * **Recurrence:** Unlike the simple LPC, the Botryoid variant has a significant recurrence rate (approx. 15-20%), requiring careful surgical enucleation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 741-742.
Explanation: **Explanation:** **Chromosomal Instability Syndromes** are a group of inherited disorders characterized by defects in **DNA repair mechanisms**. These conditions lead to an increased rate of chromosomal breakage, rearrangements, and a significantly heightened risk of developing various malignancies [1]. * **Fanconi Anemia (Option A):** This is an autosomal recessive disorder caused by a defect in the repair of **DNA interstrand cross-links** [2]. It presents with pancytopenia (bone marrow failure), radial ray defects (absent thumbs), and a high risk of AML. *Note: Do not confuse this with Fanconi Syndrome, which is a renal proximal tubule defect.* * **Ataxia-Telangiectasia (Option B):** Caused by a mutation in the **ATM gene**, which is responsible for detecting double-stranded DNA breaks [1]. It is characterized by cerebellar ataxia, oculocutaneous telangiectasias, and immunodeficiency [2]. * **Bloom Syndrome (Option C):** Caused by a mutation in the **BLM gene (RecQ helicase family)**, which is essential for maintaining genomic stability during DNA replication. Clinical features include short stature, a butterfly-shaped photosensitive rash, and "sister chromatid exchanges" [2]. Since all three conditions are classic examples of defects in DNA maintenance and repair leading to genomic fragility, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Xeroderma Pigmentosum:** Another key instability syndrome; defect in **Nucleotide Excision Repair (NER)** (inability to repair UV-induced pyrimidine dimers) [2]. * **Hereditary Non-Polyposis Colorectal Cancer (HNPCC/Lynch Syndrome):** Defect in **DNA Mismatch Repair (MMR)**. * **BRCA 1 & 2 Mutations:** Defect in **Homologous Recombination** repair. * **Common Theme:** All these syndromes predispose patients to early-onset cancers due to the accumulation of mutations [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 226-227. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 322-323.
Explanation: The bone marrow is a complex microenvironment containing various stem cell populations that contribute to tissue repair and hematopoiesis [1]. **Why Myoblast Progenitor Cells is the Correct Answer:** Myoblast progenitor cells (satellite cells) are the precursors to skeletal muscle fibers. These are **tissue-specific stem cells** located specifically between the sarcolemma and the endomysium of muscle fibers [3]. They are not found in the bone marrow. While bone marrow-derived mesenchymal stem cells can be induced to differentiate into myogenic lineages in a lab setting, the resident population of myoblasts is strictly intramuscular. **Explanation of Incorrect Options:** * **Hematopoietic Stem Cells (HSCs):** These are the primary residents of the bone marrow [1]. They are multipotent cells responsible for the continuous production of all blood cell lineages (RBCs, WBCs, and platelets) [2]. * **Mesenchymal Stem Cells (MSCs):** Also known as Multipotent Stromal Cells, these are found in the bone marrow stroma. They have the capacity to differentiate into "stromal" lineages: osteoblasts (bone), chondrocytes (cartilage), and adipocytes (fat). * **Endothelial Progenitor Cells (EPCs):** These are bone marrow-derived cells that circulate in the blood and home to sites of neovascularization (angiogenesis). They play a critical role in vascular repair and the lining of blood vessels. **High-Yield Clinical Pearls for NEET-PG:** * **HSC Marker:** CD34+ is the most characteristic surface marker used for identifying and harvesting HSCs for transplants. * **Plasticity:** The ability of an adult stem cell from one tissue to generate specialized cells of another tissue (e.g., MSCs forming neurons) is called **transdifferentiation** or plasticity [3]. * **Niche:** The "Osteoblastic Niche" in the bone marrow is where quiescent HSCs reside, while the "Vascular Niche" is where active hematopoiesis occurs [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 588-589. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 585-586. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 104-105. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, p. 1182.
Explanation: **Explanation:** Superantigens are a unique class of antigens that cause excessive, non-specific activation of the immune system. Unlike conventional antigens, they bypass the standard processing and presentation pathway. **Why Option C is the correct (False) statement:** Conventional antigens must be processed into peptides and nested within the **antigen-binding groove (cleft)** of MHC class II molecules to be recognized [1]. In contrast, **superantigens do not bind to the cleft.** Instead, they bind to the **outer (lateral) surface** of the MHC class II molecule and the Vβ chain of the T-cell receptor (TCR). This "bridge" bypasses the need for specific antigen recognition. **Analysis of other options:** * **Option A:** True. Because they bind outside the specific peptide-binding site, they activate T cells **irrespective of their antigen specificity**, leading to a polyclonal T-cell response (activating up to 20% of all T cells). * **Option B:** True. Superantigens act as a molecular glue, directly cross-linking MHC class II on antigen-presenting cells (APCs) with the TCR on T cells. * **Option D:** True. They specifically target the **variable region of the beta chain (Vβ)** on the lateral aspect of the TCR. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Massive release of cytokines (Cytokine Storm), primarily **IL-1, IL-2, TNF-α, and IFN-γ**. * **Classic Examples:** 1. *Staphylococcus aureus*: **TSST-1** (Toxic Shock Syndrome) and Enterotoxins (Food poisoning). 2. *Streptococcus pyogenes*: **Exotoxin A and C** (Streptococcal Toxic Shock-like Syndrome). * **Consequence:** The massive cytokine release leads to systemic inflammation, hypotension, multi-organ failure, and shock. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 202-203.
Explanation: **Explanation:** **Metastatic calcification** occurs when calcium salts are deposited in normal (viable) tissues due to hypercalcemia [1], [2]. It primarily affects tissues that have an **internal alkaline environment**, as alkalinity favors the precipitation of calcium salts [1]. **Why Lungs are the Correct Answer:** The lungs are a classic site for metastatic calcification because they lose carbon dioxide ($CO_2$) during respiration [1]. This loss of acid creates a **high local pH (alkalinity)** within the pulmonary tissue [1]. Other common sites following this principle include the gastric mucosa (secretes $HCl$), kidneys (excrete acid), and systemic arteries [1]. These organs are predisposed because they either secrete acid or have a high metabolic turnover that shifts the local pH toward alkalinity. **Why Other Options are Incorrect:** * **Lymph nodes:** These are common sites for **dystrophic calcification**, particularly in chronic granulomatous diseases like Tuberculosis, where calcium deposits in necrotic (dead) tissue despite normal serum calcium levels. * **Spleen & Liver:** While these organs can occasionally show calcification, it is usually dystrophic (secondary to old infections, infarcts, or granulomas) rather than metastatic. They do not possess the specific acid-excreting mechanisms that create the alkaline environment necessary for metastatic deposition. **High-Yield Clinical Pearls for NEET-PG:** * **Dystrophic vs. Metastatic:** Dystrophic occurs in *damaged* tissue with *normal* calcium levels; Metastatic occurs in *normal* tissue with *elevated* calcium levels [1]. * **Common Causes of Metastatic Calcification:** Hyperparathyroidism (most common), Vitamin D intoxication, Bone resorption (multiple myeloma, bony metastasis), and Renal failure (secondary hyperparathyroidism) [1], [2]. * **Morphology:** On H&E stain, calcium appears as **basophilic (blue-purple)**, amorphous granular clumps [1]. * **Special Stain:** **Von Kossa stain** (turns calcium black) and **Alizarin Red S** (turns calcium orange-red). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135.
Explanation: **Explanation:** The clinical presentation and histopathology describe a **Pleomorphic Adenoma** (Benign Mixed Tumor), the most common salivary gland tumor [2]. It typically presents as a painless, slow-growing, mobile mass at the angle of the jaw (parotid gland) [1]. Histologically, it is characterized by a "mixed" appearance: epithelial/myoepithelial cells arranged in ducts or sheets, interspersed within a mesenchymal-like stroma (myxoid, chondroid, or hyaline) [2]. **Why Local Recurrence is the Correct Answer:** Pleomorphic adenomas are notorious for having a **false/incomplete capsule**. Microscopic finger-like projections (pseudopods) often extend beyond the main tumor mass. If the tumor is removed via simple enucleation rather than wide excision (superficial parotidectomy), these microscopic remnants lead to a high rate of **local recurrence**, with rates approaching 25% for enucleation compared to 4% for parotidectomy [1]. **Analysis of Incorrect Options:** * **A & B (Contralateral spread/Invasion of bone):** These are features of malignancy. Pleomorphic adenoma is a benign tumor; it does not metastasize to the other side or aggressively invade bone. * **D (Malignant transformation):** While "Carcinoma ex pleomorphic adenoma" can occur, it is rare (approx. 2–10%) and usually happens after the tumor has been present for 10–15 years [1]. Local recurrence is a much more common clinical concern following surgery. **NEET-PG High-Yield Pearls:** * **Most common site:** Parotid gland (Tail of the parotid) [1]. * **Most common histological feature:** Myxoid stroma and myoepithelial cells [2]. * **PLAG1 gene:** Frequently rearranged/overexpressed in these tumors. * **Surgical Note:** Never perform a simple "incisional biopsy" or "enucleation" due to the risk of tumor seeding and recurrence; FNAC is the preferred diagnostic tool [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 751-753. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 274-276.
Explanation: **Explanation:** **Rosenthal fibers** are characteristic histopathological findings in certain low-grade gliomas, most notably **Pilocytic Astrocytoma** (WHO Grade I) and Alexander disease. **Why the correct answer is right:** Rosenthal fibers are elongated, eosinophilic, "corkscrew-shaped" intracellular inclusions found within astrocytic processes. They are primarily composed of **Glial Fibrillary Acidic Protein (GFAP)**, which is the intermediate filament specific to glial cells. These fibers represent a degenerative change or a "clumping" of these filaments, often associated with chronic reactive gliosis or slow-growing tumors. **Analysis of incorrect options:** * **A. Heat shock proteins:** While Rosenthal fibers do contain small amounts of heat shock proteins (specifically **αB-crystallin** and **HSP27**), they are not the primary structural component. GFAP is the definitive protein used for identification in pathology. * **B. Fibrillar proteins:** This is a generic term. While GFAP is a type of intermediate filament (fibrillar in nature), "GFAP" is the specific and correct pathological designation. * **C. Globulins:** These are plasma proteins (like immunoglobulins). They are found in Russell bodies (Plasma cells), not in astrocytic inclusions. **NEET-PG High-Yield Pearls:** 1. **Pilocytic Astrocytoma:** Most common brain tumor in children; typically located in the cerebellum. 2. **Biphasic Pattern:** Histology shows Rosenthal fibers (dense areas) and **Eosinophilic Granular Bodies (EGBs)** (cystic areas). 3. **Alexander Disease:** A rare leukodystrophy characterized by a mutation in the GFAP gene, leading to profuse Rosenthal fiber formation. 4. **Staining:** Rosenthal fibers are strongly eosinophilic on H&E and positive for GFAP on immunohistochemistry.
Explanation: **Explanation:** The **BRAF gene** is a proto-oncogene located on the long (q) arm of **Chromosome 7 (7q34)**. However, in the context of standard medical examinations and specific high-yield associations, it is crucial to note that the BRAF gene is frequently discussed alongside other major tumor suppressors and oncogenes. *Note: While the precise locus is Chromosome 7, in many competitive formats, BRAF is associated with the MAPK pathway and specific syndromes. If the provided options list Chromosome 17 as the correct answer, it often refers to the high-yield cluster of "17" related genes (like TP53 and NF1) or a specific error in traditional question banks. However, scientifically, BRAF is on 7q.* **Analysis of Options:** * **Chromosome 17 (Correct per key):** This chromosome is a "hotspot" for NEET-PG. It houses **TP53** (17p), **NF1** (17q), **BRCA1** (17q), and **HER2/neu** (17q) [1]. * **Chromosome 13:** Houses the **RB1** (Retinoblastoma) gene and **BRCA2**. * **Chromosome 11:** Houses the **WT1** (Wilms tumor) gene and the **Cyclin D1** (PRAD1) gene. * **Chromosome 22:** Houses the **NF2** (Merlin) gene and is part of the Philadelphia chromosome (BCR). **Clinical Pearls for NEET-PG:** 1. **V600E Mutation:** The most common BRAF mutation (Valine replaced by Glutamate). 2. **Associated Tumors:** * **Papillary Thyroid Carcinoma** (Most common mutation). * **Malignant Melanoma** (Found in ~50% of cases) [1]. * **Hairy Cell Leukemia** (Nearly 100% have BRAF V600E). * **Langerhans Cell Histiocytosis (LCH)** and **Colon Cancer** (MSI-H). 3. **Targeted Therapy:** Vemurafenib and Dabrafenib are BRAF inhibitors used in metastatic melanoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 292.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free